A1AFR

1-[(3S)-3-{4-amino-3-[(3,5-dimethoxyphenyl)ethynyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl}pyrrolidin-1-yl]propan-1-one

Created:	2024-02-23
Last modified:	2025-01-01

Find Related PDB Entry
1 entries where A1AFR is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	55
Chiral Atom Count	1
Bond Count	58
Aromatic Bond Count	16

2D diagram of A1AFR

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	1-[(3S)-3-{4-amino-3-[(3,5-dimethoxyphenyl)ethynyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl}pyrrolidin-1-yl]propan-1-one
Systematic Name (OpenEye OEToolkits)	1-[(3~{S})-3-[4-azanyl-3-[2-(3,5-dimethoxyphenyl)ethynyl]pyrazolo[3,4-d]pyrimidin-1-yl]pyrrolidin-1-yl]propan-1-one
Formula	C₂₂ H₂₄ N₆ O₃
Molecular Weight	420.464
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	CCC(=O)N1CCC(C1)n1nc(C#Cc2cc(OC)cc(OC)c2)c2c(N)ncnc21
SMILES	CACTVS	3.385	CCC(=O)N1CC[CH](C1)n2nc(C#Cc3cc(OC)cc(OC)c3)c4c(N)ncnc24
SMILES	OpenEye OEToolkits	2.0.7	CCC(=O)N1CCC(C1)n2c3c(c(n2)C#Cc4cc(cc(c4)OC)OC)c(ncn3)N
Canonical SMILES	CACTVS	3.385	CCC(=O)N1CC[C@@H](C1)n2nc(C#Cc3cc(OC)cc(OC)c3)c4c(N)ncnc24
Canonical SMILES	OpenEye OEToolkits	2.0.7	CCC(=O)N1CC[C@@H](C1)n2c3c(c(n2)C#Cc4cc(cc(c4)OC)OC)c(ncn3)N
InChI	InChI	1.06	InChI=1S/C22H24N6O3/c1-4-19(29)27-8-7-15(12-27)28-22-20(21(23)24-13-25-22)18(26-28)6-5-14-9-16(30-2)11-17(10-14)31-3/h9-11,13,15H,4,7-8,12H2,1-3H3,(H2,23,24,25)/t15-/m0/s1
InChIKey	InChI	1.06	DZLNAZQOANZLHT-HNNXBMFYSA-N

Related Resource References

Resource Name	Reference
PubChem	89870870
ChEMBL	CHEMBL3701282

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.